Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts

Leukemia

Volumn 15, Issue 5, 2001, Pages 742-751

  Schmidt Mende, J ^a,b   Tehranchi, R ^b   Forsblom, A M ^b   Joseph, B ^a   Christensson, B ^b   Fadeel, B ^a   Zhivotovsky, B ^a   Hellstrom Lindberg E ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Caspase; Fas; G CSF; Myelodysplasia; Sideroblast

Indexed keywords

CASPASE; CASPASE 3; CASPASE 8; CD34 ANTIGEN; ERYTHROPOIETIN; FAS ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; ERYTHROID CELL; FEMALE; HEMATOPOIETIC STEM CELL; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MYELODYSPLASTIC SYNDROME; PATHOLOGY; PRIORITY JOURNAL; REFRACTORY ANEMIA;

EID: 0035013475     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402110     Document Type: Article

References (50)

1. From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes
2. Apoptosis is a common histopatholgical finding in myelodysplasia: The correlate of ineffective hematopoiesis
3. Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin
4. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes
5. Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin
6. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a sub-group of responders. The Spanish Erythropathology Group
7. Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: Results from a randomized phase II study and long-term follow-up of 71 patients
8. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: Proposal for a predictive model
9. A combination of granulocyte colony-stimulating factor and erythropoietin may synergistically improve the anaemia in patients with myelodysplastic syndromes
10. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy
11. Use of G-CSF to mobilise PBSC in normal healthy donors - An international survey
12. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis
13. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis
14. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes
15. Fas/APO-1 (CD95) expression in myelodysplastic syndromes
16. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia
17. A role for tumour necrosis factor-alpha, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome
18. CD95 (APO-1/FAS)-mediated apoptosis in cytokine-activated hematopoietic cells
19. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro
20. Fas antigen (CD95) and hematopoietic progenitor cells
21. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes
22. Evidence for involvement of tumor necrosis factor-alpha in apoptotic death of bone marrow cells in myelodysplastic syndromes
23. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells
24. 'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins
25. The most unkindest cut of all: On the multiple roles of mammalian caspases
26. Caspases: The executioners of apoptosis
27. Apoptosis in refractory anemia with ringed sideroblasts is initiated at the stem cell level and is associated with increased activation of caspases
28. Activity of the caspase-3/CPP32 enzyme is increased in 'early stage' myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro
29. Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes
30. Correlation of tumor necrosis factor alpha (TNF alpha) with high caspase 3-like activity in myelodysplastic syndromes
31. Apoptosis and its significance in MDS: Controversies revisited
32. Mitochondria and apoptosis
33. The mitochondrial permeability transition pore and its role in cell death
34. Freezing induces artificial cleavage of apoptosis-related proteins in human bone marrow cells
35. Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells
36. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
37. Functional characterization of Jurkat T cells rescued from CD95/Fas-induced apoptosis through the inhibition of caspases
38. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways
39. Expression and activity of caspases 1 and 3 in myelodysplastic syndromes
40. Regulation of Fas antibody induced neutrophil apoptosis is both caspase and mitochondrial dependent
41. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells
42. Two pathways of apoptosis induced with all-trans retinoic acid and etoposide in the myeloid cell line P39
43. G-CSF-mobilized CD34 peripheral blood stem cells are significantly less apoptotic than unstimulated peripheral blood CD34 cells: Role of G-CSF as survival factor
44. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
45. Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival
46. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors
47. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression
48. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2
49. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation
50. Swapping between Fas and granulocyte colony-stimulating factor receptor